Prominent Abia-born cleric, Rev. Chika Ubani, has
reacted strongly to Senator Orji Uzor Kalu’s recent remarks about the 2027 Abia
North Senatorial election, insisting that the people of the state will not
accept any decision by Kalu to withdraw from the race.
Kalu, a former governor of Abia State and the current
senator representing Abia North, had stated that his focus remains on
delivering good governance rather than engaging in discussions about the 2027
elections.
Speaking on his priorities, Kalu said: “My focus right
now is not on the politics of 2027 but on the people of Abia North Senatorial
District and how to improve their lives because there is hunger in the land. I
can’t be talking about politics when my people are hungry.
“Though I appreciate all the endorsements from our
people at home and abroad, we still have the mandate given to us in 2023.
“My priority at the moment is to deliver more
dividends of democracy, put smiles on the faces of my people, and support
President Bola Ahmed Tinubu and other patriotic Nigerians in tackling the
issues affecting the progress of our great nation.”
However, in a sharp response, Rev. Ubani dismissed any
possibility of Kalu stepping aside, declaring that Abians would not accept such
a move.
According to Ubani, Kalu remains the best thing to
happen to Abia State and Abia North, emphasizing that the people of the state
are pressuring him to seek re-election.
“Senator Orji Uzor Kalu has proven himself as a leader
who prioritises the welfare of his people. He has brought development,
infrastructure, and good governance to Abia North and beyond. The entire state
is forcing him to run again, and we won’t accept any decision to step aside,”
Ubani said.
The remarks by both men have sparked fresh political
conversations in Abia North, as stakeholders and residents continue to debate
Kalu’s future in the Senate. While some applaud his commitment to governance
over early politicking, others, like Rev. Ubani, believe his leadership remains
indispensable to Abia’s progress.
Comments:
Leave a Reply